Generalized Pustular Psoriasis
Also known as: Generalized Pustular Psoriasis (GPP) / Impetigo herpetiformis / Generalized pustular psoriasis (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB15626 | Spesolimab | An interleukin-36 receptor antagonist used to treat generalized pustular psoriasis flares in adults. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB15626 | Spesolimab | Interleukin-1 receptor-like 2 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB16658 | Imsidolimab | 2 | Completed | 1 |
DB15626 | Spesolimab | 2 | Active Not Recruiting | 1 |
DB15626 | Spesolimab | 2 | Completed | 2 |
DB00051 | Adalimumab | 3 | Completed | 1 |
DB16658 | Imsidolimab | 3 | Active Not Recruiting | 1 |
DB16658 | Imsidolimab | 3 | Completed | 1 |
DB15626 | Spesolimab | 3 | Completed | 2 |
DB11569 | Ixekizumab | 4 | Completed | 1 |
DB15626 | Spesolimab | 4 | Recruiting | 1 |
DB15626 | Spesolimab | Not Available | Recruiting | 1 |